<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Medico — Februar 2022]]></title><description><![CDATA[<p dir="auto">Denne ugekommentar dedikerer Helge Larsen til biotech, nærmere bestemt den nedtur, sektoren har oplevet og stadig oplever. Han kigger bl.a. ned i mulige årsager som rentestigninger, sektorrotation - men også over på markedet i USA med NBI-indekset og mekanismerne her. <a href="https://www.proinvestor.com/boards/100739/Ugekommentaren-Nedturen-i-biotech" rel="nofollow ugc">https://www.proinvestor.com/boards/100739/Ugekommentaren-Nedturen-i-biotech</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400912/medico-februar-2022</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 16:52:28 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400912.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 03 Feb 2022 13:43:20 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Medico — Februar 2022 on Tue, 22 Feb 2022 08:28:02 GMT]]></title><description><![CDATA[<p dir="auto">Britisk Coloplast-konkurrent stiger efter regnskab og ny topchef <a href="https://proinvestor.com/investornyt/785010/britisk-coloplast-konkurrent-stiger-efter-regnskab-og-ny-topchef" rel="nofollow ugc">https://proinvestor.com/investornyt/785010/britisk-coloplast-konkurrent-stiger-efter-regnskab-og-ny-topchef</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038401</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038401</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 22 Feb 2022 08:28:02 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Sat, 12 Feb 2022 12:01:07 GMT]]></title><description><![CDATA[<p dir="auto">Here's How Healthcare Stocks Have Historically Performed After a Down January <a href="https://www.proinvestor.com/investornyt/780839/heres-how-healthcare-stocks-have-historically-performed-after-a-down-january" rel="nofollow ugc">https://www.proinvestor.com/investornyt/780839/heres-how-healthcare-stocks-have-historically-performed-after-a-down-january</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038398</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038398</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 12 Feb 2022 12:01:07 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Fri, 11 Feb 2022 11:39:04 GMT]]></title><description><![CDATA[<p dir="auto">Demant/Kepler Cheuvreux: Anbefaling løftes til "hold" fra "reducer" <a href="https://proinvestor.com/investornyt/780352/demant-kepler-cheuvreux-anbefaling-loftes-til-hold-fra-reducer" rel="nofollow ugc">https://proinvestor.com/investornyt/780352/demant-kepler-cheuvreux-anbefaling-loftes-til-hold-fra-reducer</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038395</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038395</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 11 Feb 2022 11:39:04 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Fri, 11 Feb 2022 04:53:20 GMT]]></title><description><![CDATA[<p dir="auto">GN/JPMorgan: Hæver anbefaling til "overvægt" <a href="https://proinvestor.com/investornyt/780216/gn-jpmorgan-haever-anbefaling-til-overvaegt" rel="nofollow ugc">https://proinvestor.com/investornyt/780216/gn-jpmorgan-haever-anbefaling-til-overvaegt</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038397</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038397</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 11 Feb 2022 04:53:20 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Thu, 10 Feb 2022 07:45:52 GMT]]></title><description><![CDATA[<p dir="auto">GN Audio/CEO: Klassisk forretning rammes hårdest af forsyningsknas -NY <a href="https://proinvestor.com/investornyt/779422/gn-audio-ceo-klassisk-forretning-rammes-hardest-af-forsyningsknas-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/779422/gn-audio-ceo-klassisk-forretning-rammes-hardest-af-forsyningsknas-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038394</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038394</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 10 Feb 2022 07:45:52 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Thu, 10 Feb 2022 07:22:02 GMT]]></title><description><![CDATA[<p dir="auto">GN Hearing/CEO: Nye produkter tager tid at få op i kadence <a href="https://proinvestor.com/investornyt/779386/gn-hearing-ceo-nye-produkter-tager-tid-at-fa-op-i-kadence" rel="nofollow ugc">https://proinvestor.com/investornyt/779386/gn-hearing-ceo-nye-produkter-tager-tid-at-fa-op-i-kadence</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038400</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038400</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 10 Feb 2022 07:22:02 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Thu, 10 Feb 2022 06:15:12 GMT]]></title><description><![CDATA[<p dir="auto">GN vil vokse mere end markedet i vanskeligt år - NY <a href="https://proinvestor.com/investornyt/779381/gn-vil-vokse-mere-end-markedet-i-vanskeligt-ar-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/779381/gn-vil-vokse-mere-end-markedet-i-vanskeligt-ar-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038391</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038391</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 10 Feb 2022 06:15:12 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Thu, 10 Feb 2022 06:09:37 GMT]]></title><description><![CDATA[<p dir="auto">GN/Sydbank: Vækst på 10 pct. for Steelseries-opkøb er positivt - NY <a href="https://proinvestor.com/investornyt/779376/gn-sydbank-vaekst-pa-10-pct-for-steelseries-opkob-er-positivt-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/779376/gn-sydbank-vaekst-pa-10-pct-for-steelseries-opkob-er-positivt-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038393</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038393</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 10 Feb 2022 06:09:37 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Tue, 08 Feb 2022 13:21:15 GMT]]></title><description><![CDATA[<p dir="auto">GN Hearing/CEO: Jabra Enhance Plus påvirker salgsprognose positivt<br />
<a href="https://www.proinvestor.com/investornyt/778119/gn-hearing-ceo-jabra-enhance-plus-pavirker-salgsprognose-positivt" rel="nofollow ugc">https://www.proinvestor.com/investornyt/778119/gn-hearing-ceo-jabra-enhance-plus-pavirker-salgsprognose-positivt</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038390</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038390</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 08 Feb 2022 13:21:15 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Tue, 08 Feb 2022 08:52:31 GMT]]></title><description><![CDATA[<p dir="auto">Demant/CEO: Vi er igen på vej frem i Communications og implantater <a href="https://proinvestor.com/investornyt/777928/demant-ceo-vi-er-igen-pa-vej-frem-i-communications-og-implantater" rel="nofollow ugc">https://proinvestor.com/investornyt/777928/demant-ceo-vi-er-igen-pa-vej-frem-i-communications-og-implantater</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038388</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038388</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 08 Feb 2022 08:52:31 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Tue, 08 Feb 2022 08:27:26 GMT]]></title><description><![CDATA[<p dir="auto">Demant/CEO: To ekstraordinære ting i 2021 kan mudre EBIT-konsensus -NY <a href="https://proinvestor.com/investornyt/777923/demant-ceo-to-ekstraordinaere-ting-i-2021-kan-mudre-ebit-konsensus-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/777923/demant-ceo-to-ekstraordinaere-ting-i-2021-kan-mudre-ebit-konsensus-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038392</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038392</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 08 Feb 2022 08:27:26 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Tue, 08 Feb 2022 08:14:22 GMT]]></title><description><![CDATA[<p dir="auto">Demant OVERBLIK H2: EBIT-prognose presser indtrykket af rekordregnskab <a href="https://proinvestor.com/investornyt/777917/demant-overblik-h2-ebit-prognose-presser-indtrykket-af-rekordregnskab" rel="nofollow ugc">https://proinvestor.com/investornyt/777917/demant-overblik-h2-ebit-prognose-presser-indtrykket-af-rekordregnskab</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038396</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038396</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 08 Feb 2022 08:14:22 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Tue, 08 Feb 2022 06:22:44 GMT]]></title><description><![CDATA[<p dir="auto">GN/SEB: Skærer kursmålet ned med 40 kr. til 500 kr. <a href="https://proinvestor.com/investornyt/777887/gn-seb-skaerer-kursmalet-ned-med-40-kr-til-500-kr" rel="nofollow ugc">https://proinvestor.com/investornyt/777887/gn-seb-skaerer-kursmalet-ned-med-40-kr-til-500-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038389</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038389</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 08 Feb 2022 06:22:44 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Tue, 08 Feb 2022 06:20:25 GMT]]></title><description><![CDATA[<p dir="auto">Demant H2: Væksten og driften skuffer en smule - NY2 <a href="https://proinvestor.com/investornyt/777901/demant-h2-vaeksten-og-driften-skuffer-en-smule-ny2" rel="nofollow ugc">https://proinvestor.com/investornyt/777901/demant-h2-vaeksten-og-driften-skuffer-en-smule-ny2</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038387</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038387</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 08 Feb 2022 06:20:25 GMT</pubDate></item><item><title><![CDATA[Reply to Medico — Februar 2022 on Tue, 08 Feb 2022 06:20:09 GMT]]></title><description><![CDATA[<p dir="auto">Demant H2: Væksten skuffer en smule - NY <a href="https://proinvestor.com/investornyt/777892/demant-h2-vaeksten-skuffer-en-smule-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/777892/demant-h2-vaeksten-skuffer-en-smule-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038399</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038399</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 08 Feb 2022 06:20:09 GMT</pubDate></item></channel></rss>